MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by Rossaporinoon Nov 27, 2020 9:10am

852 Views

Post# 31987862

Mir

The test was developed and validated using MedMira’s Rapid Vertical Flow Technology. This platform is US Food and Drug Administration-approved that has received regulatory approval in multiple countries. The platform has been used for more than a decade to test for other infectious diseases including HIV, hepatitis B and C, and syphilis. The coronavirus disease 2019 test will be manufactured in the United States and will be called REVEALCOVID-19.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market